Virulence factors and O-Serogroups profiles of uropathogenic Escherichia coli isolated from Iranian pediatric patients

Iranian Red Crescent Medical Journal

Volumn 16, Issue 2, 2014, Pages

  Dormanesh, Banafshe ^a   Safarpoor Dehkordi, Farhad ^b   Momtaz, Hassan ^b   Mirnejad, Reza ^c   Hoseini, Mohammad Javad ^c   Yahaghi, Emad ^d   Tarhriz, Vahideh ^e   Khodaverdi Darian, Ebrahim ^f  

^a AJA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e UNIVERSITY OF TABRIZ   (Iran)

^f ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Iran; Pediatrics; Uropathogenic Escherichia Coli

Indexed keywords

ADHESIN; AFIMBRIAL ADHESIN; CYTOTOXIC NECROTIZING FACTOR 1; HEMOLYSIN; PANCREATITIS ASSOCIATED PROTEIN; S FIMBRIAL ADHESIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; BACTERIUM DISTRIBUTION; CHILD; CROSS-SECTIONAL STUDY; FEMALE; GEL ELECTROPHORESIS; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; SEROTYPE; URINALYSIS; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84893232653     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: 10.5812/ircmj.14627     Document Type: Article

References (33)

1. Jadhav S, Hussain A, Devi S, Kumar A, Parveen S, Gandham N, et al. Virulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi urban locality in India. PLoS One. 2011;6(3).
2. WHO. Urinary Tract Infections in Infants and Children in Developing Countries in the Context of IMCI. World Health Organization. Geneva, Switzerland; 2005.
3. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003;49(2):53-70.
4. Momtaz H, Dehkordi FS, Rahimi E, Asgarifar A. Detection of Escherichia coli, Salmonella species, and Vibrio cholerae in tap water and bottled drinking water in Isfahan, Iran. BMC Public Health. 2013;13(1):556.
5. Soto SM, Guiral E, Bosch J, Vila J. Prevalence of the set-1B and astA genes encoding enterotoxins in uropathogenic Escherichia coli clinical isolates. Microb Pathog. 2009;47(6):305-7.
6. Bauer RJ, Zhang L, Foxman B, Siitonen A, Jantunen ME, Saxen H, et al. Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN(E. coli). J Infect Dis. 2002;185(10):1521-4.
7. Abe CM, Salvador FA, Falsetti IN, Vieira MA, Blanco J, Blanco JE, et al. Uropathogenic Escherichia coli (UPEC) strains may carry virulence properties of diarrhoeagenic E. coli. FEMS Immunol Med Microbiol. 2008;52(3):397-406.
8. Ananias M, Yano T. Serogroups and virulence genotypes of Escherichia coli isolated from patients with sepsis. Braz J Med Biol Res. 2008;41(10):877-83.
9. Bidet P, Mahjoub-Messai F, Blanco J, Blanco J, Dehem M, Aujard Y, et al. Combined multilocus sequence typing and O serogrouping distinguishes Escherichia coli subtypes associated with infant urosepsis and/or meningitis. J Infect Dis. 2007;196(2):297-303.
10. Yamamoto S. Molecular epidemiology of uropathogenic Escherichia coli. J Infect Chemother. 2007;13(2):68-73.
11. Li D, Liu B, Chen M, Guo D, Guo X, Liu F, et al. A multiplex PCR method to detect 14 Escherichia coli serogroups associated with urinary tract infections. J Microbiol Methods. 2010;82(1):71-7.
12. Yamamoto S, Terai A, Yuri K, Kurazono H, Takeda Y, Yoshida O. Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol Med Microbiol. 1995;12(2):85-90.
13. Le Bouguenec C. Adhesins and invasins of pathogenic Escherichia coli. Int J Med Microbiol. 2005;295(6-7):471-8.
14. Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J. 2008;27(4):302-8.
15. Vollmerhausen TL, Ramos NL, Gundogdu A, Robinson W, Brauner A, Katouli M. Population structure and uropathogenic virulence-associated genes of faecal Escherichia coli from healthy young and elderly adults. J Med Microbiol. 2011;60(Pt 5):574-81.
16. Fathollahi S, Yousefi_Mashouf R, Goodarzi MT, Hajilooei M, Hemati S, Mostafaei A, et al. Typing of the uropathogenic E. coli strains using. Iranian J Clin Infect Dis. 2009;4(2):77-81.
17. Hagan EC, Mobley HL. Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun. 2007;75(8):3941-9.
18. Molina-Lopez J, Aparicio-Ozores G, Ribas-Aparicio RM, Gavilanes-Parra S, Chavez-Berrocal ME, Hernandez-Castro R, et al. Drug resistance, serotypes, and phylogenetic groups among uropathogenic Escherichia coli including O25-ST131 in Mexico City. J Infect Dev Ctries. 2011;5(12):840-9.
19. Emamghoraishi F, Farshad S, Kalani M. Relationship between O serotype and virulent genes in Escherichia coli causing urinary tract infections. Iran J Kidney Dis. 2011;5(4):234-7.
20. Takahashi A, Kanamaru S, Kurazono H, Kunishima Y, Tsukamoto T, Ogawa O, et al. Escherichia coli isolates associated with uncomplicated and complicated cystitis and asymptomatic bacteriuria possess similar phylogenies, virulence genes, and O-serogroup profiles. J Clin Microbiol. 2006;44(12):4589-92.
21. Arabi S. The Common Fimbarie genotyping in Uropathogenic Escherichia coli. Ann Biol Res. 2012;3(10):4951-4.
22. Momtaz H, Karimian A, Madani M, Safarpoor Dehkordi F, Ranjbar R, Sarshar M, et al. Uropathogenic Escherichia coli in Iran: serogroup distributions, virulence factors and antimicrobial resistance properties. Ann Clin Microbiol Antimicrob. 2013;12:8.
23. Asadi KM, Oloomi M, Habibi M, Bouzari S. Cloning of fimH and fliC and expression of the fusion protein FimH/FliC from Uropathogenic Escherichia coli (UPEC) isolated in Iran. Iran J Microbiol. 2012;4(2):55-62.
24. Godaly G, Bergsten G, Frendeus B, Hang L, Hedlund M, Karpman D, et al. Innate defences and resistance to gram negative mucosal infection. Adv Exp Med Biol. 2000;485:9-24.
25. Fischer H, Ellstrom P, Ekstrom K, Gustafsson L, Gustafsson M, Svanborg C. Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4. Cell Microbiol. 2007;9(5):1239-51.
26. Bergsten G, Wullt B, Svanborg C. Escherichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract. Int J Med Microbiol. 2005;295(6-7):487-502.
27. Mulvey MA. Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol. 2002;4(5):257-71.
28. Mills M, Meysick KC, O'Brien AD. Cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli kills cultured human uroepithelial 5637 cells by an apoptotic mechanism. Infect Immun. 2000;68(10):5869-80.
29. Bien J, Sokolova O, Bozko P. Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage. Int J Nephrol. 2012;2012:681473.
30. Los FC, Randis TM, Aroian RV, Ratner AJ. Role of pore-forming toxins in bacterial infectious diseases. Microbiol Mol Biol Rev. 2013;77(2):173-207.
31. Chen M, Jahnukainen T, Bao W, Dare E, Ceccatelli S, Celsi G. Uropathogenic Escherichia coli toxins induce caspase-independent apoptosis in renal proximal tubular cells via ERK signaling. Am J Nephrol. 2003;23(3):140-51.
32. Smith YC, Grande KK, Rasmussen SB, O'Brien AD. Novel three-dimensional organoid model for evaluation of the interaction of uropathogenic Escherichia coli with terminally differentiated human urothelial cells. Infect Immun. 2006;74(1):750-7.
33. Russo TA, Davidson BA, Genagon SA, Warholic NM, Macdonald U, Pawlicki PD, et al. E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model. Am J Physiol Lung Cell Mol Physiol. 2005;289(2):L207-16.